AYUR — Ayurcann Holdings Income Statement
0.000.00%
- CA$4.87m
- CA$10.05m
- CA$25.16m
- 65
- 40
- 35
- 44
Annual income statement for Ayurcann Holdings, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 September 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 7.63 | 9.39 | 12.5 | 25.2 |
Cost of Revenue | |||||
Gross Profit | — | 4.63 | 2.22 | 3.68 | 8.47 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.245 | 7.36 | 12.7 | 17.8 | 28.4 |
Operating Profit | -0.245 | 0.271 | -3.33 | -5.34 | -3.25 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.237 | 0.057 | -3.42 | -5.31 | -3.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.237 | -0.278 | -3.09 | -5.31 | -3.97 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.237 | -0.278 | -3.09 | -5.31 | -3.97 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.237 | -0.278 | -3.09 | -5.31 | -3.97 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.015 | 0.011 | -0.026 | -0.035 | -0.02 |